Arrhythmogenic Right Ventricular Cardiomyopathy

Marcus, 1998, Guy Fontaine: a pioneer in electrophysiology, Clin Cardiol, 21, 145, 10.1002/clc.4960210221 Marcus, 1982, Right ventricular dysplasia: a report of 24 adult cases, Circulation, 65, 384, 10.1161/01.CIR.65.2.384 Burke, 1998, Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases?, Circulation, 97, 1571, 10.1161/01.CIR.97.16.1571 Miles, 2019, Sudden death and left ventricular involvement in arrhythmogenic cardiomyopathy, Circulation, 139, 1786, 10.1161/CIRCULATIONAHA.118.037230 Towbin, 2019, 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: executive summary, Heart Rhythm, 16, e373, 10.1016/j.hrthm.2019.09.019 Vermij, 2017, Refining the molecular organization of the cardiac intercalated disc, Cardiovasc Res, 113, 259, 10.1093/cvr/cvw259 Zhao, 2019, Intercalated discs: cellular adhesion and signaling in heart health and diseases, Heart Fail Rev, 24, 115, 10.1007/s10741-018-9743-7 Bays, 2014, Vinculin phosphorylation differentially regulates mechanotransduction at cell-cell and cell-matrix adhesions, J Cell Biol, 205, 251, 10.1083/jcb.201309092 Lombardi, 2011, Molecular genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy: a disease of cardiac stem cells, Pediatr Cardiol, 32, 360, 10.1007/s00246-011-9890-2 Mallat, 1996, Evidence of apoptosis in arrhythmogenic right ventricular dysplasia, N Engl J Med, 335, 1190, 10.1056/NEJM199610173351604 Delmar, 2010, The cardiac desmosome and arrhythmogenic cardiomyopathies: from gene to disease, Circ Res, 107, 700, 10.1161/CIRCRESAHA.110.223412 Harmon, 2013, Structural and functional diversity of desmosomes, Cell Commun Adhes, 20, 171, 10.3109/15419061.2013.855204 Oxford, 2007, Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells, Circ Res, 101, 703, 10.1161/CIRCRESAHA.107.154252 Sato, 2009, Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes, Circ Res, 105, 523, 10.1161/CIRCRESAHA.109.201418 Kumar, 1996, The gap junction communication channel, Cell, 84, 381, 10.1016/S0092-8674(00)81282-9 Sato, 2011, Interactions between ankyrin-G, plakophilin-2, and connexin43 at the cardiac intercalated disc, Circ Res, 109, 193, 10.1161/CIRCRESAHA.111.247023 James, 2021, An international evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy (ARVC) using the ClinGen Framework, Circ Genom Precis Med, 14, 10.1161/CIRCGEN.120.003273 Rehm, 2015, ClinGen--the clinical genome resource, N Engl J Med, 372, 2235, 10.1056/NEJMsr1406261 te Riele, 2015, Arrhythmogenic right ventricular dysplasia/cardiomyopathy in the pediatric population: clinical characterization and comparison with adult-onset disease, J Am Coll Cardiol EP, 1, 551 Xu, 2017, Genotype-phenotype relationship in patients with arrhythmogenic right ventricular cardiomyopathy caused by desmosomal gene mutations: a systematic review and meta-analysis, Sci Rep, 7, 41387, 10.1038/srep41387 Gandjbakhch, 2018, Clinical diagnosis, imaging, and genetics of arrhythmogenic right ventricular cardiomyopathy/dysplasia: JACC state-of-the-art review, J Am Coll Cardiol, 72, 784, 10.1016/j.jacc.2018.05.065 Austin, 2019, Molecular mechanisms of arrhythmogenic cardiomyopathy, Nat Rev Cardiol, 16, 519, 10.1038/s41569-019-0200-7 James, 2020, The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy, Eur Heart J, 41, 1393, 10.1093/eurheartj/ehaa141 Groeneweg, 2015, Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members, Circ Cardiovasc Genet, 8, 437, 10.1161/CIRCGENETICS.114.001003 Pilichou, 2006, Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy, Circulation, 113, 1171, 10.1161/CIRCULATIONAHA.105.583674 McKoy, 2000, Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease), Lancet, 355, 2119, 10.1016/S0140-6736(00)02379-5 Watkins, 2009, Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa, Heart Rhythm, 6, S10, 10.1016/j.hrthm.2009.08.018 Xu, 2010, Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy, J Am Coll Cardiol, 55, 587, 10.1016/j.jacc.2009.11.020 Bauce, 2010, Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia, Heart Rhythm, 7, 22, 10.1016/j.hrthm.2009.09.070 Siragam, 2014, TMEM43 mutation p.S358L alters intercalated disc protein expression and reduces conduction velocity in arrhythmogenic right ventricular cardiomyopathy, PLoS One, 9, 10.1371/journal.pone.0109128 Otten, 2010, Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks, Heart Rhythm, 7, 1058, 10.1016/j.hrthm.2010.04.023 van der Zwaag, 2012, Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy, Eur J Heart Fail, 14, 1199, 10.1093/eurjhf/hfs119 Deo, 2011, Relative contribution of changes in sodium current versus intercellular coupling on reentry initiation in 2-dimensional preparations of plakophilin-2-deficient cardiac cells, Heart Rhythm, 8, 1740, 10.1016/j.hrthm.2011.06.029 Cerrone, 2017, Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm, Nat Commun, 8, 106, 10.1038/s41467-017-00127-0 Kim, 2019, Disruption of Ca(2+)(i) homeostasis and connexin 43 hemichannel function in the right ventricle precedes overt arrhythmogenic cardiomyopathy in plakophilin-2-deficient mice, Circulation, 140, 1015, 10.1161/CIRCULATIONAHA.119.039710 Garcia-Pavia, 2011, Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinicopathological study, Heart, 97, 1744, 10.1136/hrt.2011.227967 Basso, 2008, Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria, Eur Heart J, 29, 2760, 10.1093/eurheartj/ehn415 Te Riele, 2013, Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced, J Cardiovasc Electrophysiol, 24, 1311, 10.1111/jce.12222 Lombardi, 2011, Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy, Circ Res, 109, 1342, 10.1161/CIRCRESAHA.111.255075 Garcia-Gras, 2006, Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy, J Clin Invest, 116, 2012, 10.1172/JCI27751 Chen, 2014, The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy, Circ Res, 114, 454, 10.1161/CIRCRESAHA.114.302810 Kemi, 2004, Aerobic fitness is associated with cardiomyocyte contractile capacity and endothelial function in exercise training and detraining, Circulation, 109, 2897, 10.1161/01.CIR.0000129308.04757.72 Corrado, 2006, Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program, JAMA, 296, 1593, 10.1001/jama.296.13.1593 Calkins, 2017, Risk stratification in arrhythmogenic right ventricular cardiomyopathy, Circulation, 136, 2068, 10.1161/CIRCULATIONAHA.117.030792 Corrado, 2017, Arrhythmogenic cardiomyopathy, Circ Res, 121, 784, 10.1161/CIRCRESAHA.117.309345 Nava, 2000, Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy, J Am Coll Cardiol, 36, 2226, 10.1016/S0735-1097(00)00997-9 Peters, 2004, Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital, Int J Cardiol, 97, 499, 10.1016/j.ijcard.2003.10.037 Krahn, 2016, The Canadian Arrhythmogenic Right Ventricular Cardiomyopathy Registry: rationale, design, and preliminary recruitment, Can J Cardiol, 32, 1396, 10.1016/j.cjca.2016.04.004 Krahn, 2009, Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER), Circulation, 120, 278, 10.1161/CIRCULATIONAHA.109.853143 van der Werf, 2010, Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in the Netherlands, Heart Rhythm, 7, 1383, 10.1016/j.hrthm.2010.05.036 te Riele, 2016, Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy, Eur Heart J, 37, 755, 10.1093/eurheartj/ehv387 Marcus, 2010, Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria, Eur Heart J, 31, 806, 10.1093/eurheartj/ehq025 McKenna, 1994, Br Heart J, 71, 215, 10.1136/hrt.71.3.215 Bhonsale, 2017, Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation, Heart Rhythm, 14, 883, 10.1016/j.hrthm.2017.02.013 Cardona-Guarache, 2019, Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy: prevalence, echocardiographic predictors, and treatment, J Cardiovasc Electrophysiol, 30, 1801, 10.1111/jce.14069 Gilotra, 2017, Heart failure is common and under-recognized in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia, Circ Heart Fail, 10, 10.1161/CIRCHEARTFAILURE.116.003819 Kimura, 2017, Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: what are the risk factors?, Int J Cardiol, 241, 288, 10.1016/j.ijcard.2017.04.061 Protonotarios, 2004, Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy, Cardiovasc Pathol, 13, 185, 10.1016/j.carpath.2004.03.609 Cox, 2008, Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/cardiomyopathy: toward improvement of diagnostic ECG criteria, J Cardiovasc Electrophysiol, 19, 775, 10.1111/j.1540-8167.2008.01140.x Platonov, 2016, High interobserver variability in the assessment of epsilon waves: Implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia, Heart Rhythm, 13, 208, 10.1016/j.hrthm.2015.08.031 Bosman, 2020, Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 task force criteria: clinical performance and simplified practical implementation, Europace, 22, 787, 10.1093/europace/euaa039 Quarta, 2010, Dynamic electrocardiographic changes in patients with arrhythmogenic right ventricular cardiomyopathy, Heart, 96, 516, 10.1136/hrt.2009.182949 Bae, 2014, Changes in follow-up ECG and signal-averaged ECG in patients with arrhythmogenic right ventricular cardiomyopathy, Pacing Clin Electrophysiol, 37, 430, 10.1111/pace.12285 Saguner, 2015, Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia, BMC Cardiovasc Disord, 15, 4, 10.1186/1471-2261-15-4 Kamath, 2011, Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia, Heart Rhythm, 8, 256, 10.1016/j.hrthm.2010.10.007 Folino, 2006, Long-term follow-up of the signal-averaged ECG in arrhythmogenic right ventricular cardiomyopathy: correlation with arrhythmic events and echocardiographic findings, Europace, 8, 423, 10.1093/europace/eul035 Sharma, 2019, Misdiagnosis of ARVC leading to inappropriate ICD implant and subsequent ICD removal - lessons learned, J Cardiovasc Electrophysiol, 30, 2020, 10.1111/jce.14088 Mast, 2017, Evaluation of structural progression in arrhythmogenic right ventricular dysplasia/cardiomyopathy, JAMA Cardiol, 2, 293, 10.1001/jamacardio.2016.5034 Taha, 2020, Evaluation of disease progression in arrhythmogenic cardiomyopathy: the change of echocardiographic deformation characteristics over time, J Am Coll Cardiol Img, 13, 631, 10.1016/j.jcmg.2019.08.014 Femia, 2019, Long term CMR follow up of patients with right ventricular abnormality and clinically suspected arrhythmogenic right ventricular cardiomyopathy (ARVC), J Cardiovasc Magn Reson, 21, 76, 10.1186/s12968-019-0581-0 te Riele, 2015, Noninvasive Multimodality Imaging in ARVD/C, J Am Coll Cardiol Img, 8, 597, 10.1016/j.jcmg.2015.02.007 Haugaa, 2017, Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging, Eur Heart J Cardiovasc Imaging, 18, 237, 10.1093/ehjci/jew229 Kimura, 2010, Myocardial fat at cardiac imaging: how can we differentiate pathologic from physiologic fatty infiltration?, Radiographics, 30, 1587, 10.1148/rg.306105519 Nakajima, 2013, Utility of ECG-gated MDCT to differentiate patients with ARVC/D from patients with ventricular tachyarrhythmias, J Cardiovasc Comput Tomogr, 7, 223, 10.1016/j.jcct.2013.05.004 Clayton, 2014, Assessment of the myocardium with cardiac computed tomography, Eur Heart J Cardiovasc Imaging, 15, 603, 10.1093/ehjci/jeu028 Angelini, 1993, Endomyocardial biopsy in right ventricular cardiomyopathy, Int J Cardiol, 40, 273, 10.1016/0167-5273(93)90011-5 Tabib, 2003, Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia, Circulation, 108, 3000, 10.1161/01.CIR.0000108396.65446.21 Thiene, 1988, Right ventricular cardiomyopathy and sudden death in young people, N Engl J Med, 318, 129, 10.1056/NEJM198801213180301 Thiene, 2015, The research venture in arrhythmogenic right ventricular cardiomyopathy: a paradigm of translational medicine, Eur Heart J, 36, 837, 10.1093/eurheartj/ehu493 Paul, 2011, Safety of endomyocardial biopsy in patients with arrhythmogenic right ventricular cardiomyopathy: a study analyzing 161 diagnostic procedures, J Am Coll Cardiol Intv, 4, 1142, 10.1016/j.jcin.2011.06.015 Avella, 2008, Diagnostic value of endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular cardiomyopathy/dysplasia, J Cardiovasc Electrophysiol, 19, 1127, 10.1111/j.1540-8167.2008.01228.x Pieroni, 2009, High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy differential diagnosis by electroanatomic mapping-guided endomyocardial biopsy, J Am Coll Cardiol, 53, 681, 10.1016/j.jacc.2008.11.017 Corrado, 2020, Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis, Eur Heart J, 41, 1414, 10.1093/eurheartj/ehz669 Kapplinger, 2011, Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise, J Am Coll Cardiol, 57, 2317, 10.1016/j.jacc.2010.12.036 Lahtinen, 2011, Population-prevalent desmosomal mutations predisposing to arrhythmogenic right ventricular cardiomyopathy, Heart Rhythm, 8, 1214, 10.1016/j.hrthm.2011.03.015 Hall, 2018, Frequency of genetic variants associated with arrhythmogenic right ventricular cardiomyopathy in the genome aggregation database, Eur J Hum Genet, 26, 1312, 10.1038/s41431-018-0169-4 Headrick, 2019, Incidentally identified genetic variants in arrhythmogenic right ventricular cardiomyopathy-associated genes among children undergoing exome sequencing reflect healthy population variation, Mol Genet Genomic Med, 7, e593, 10.1002/mgg3.593 Marcus, 2013, Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians, J Am Coll Cardiol, 61, 1945, 10.1016/j.jacc.2013.01.073 Deshpande, 2016, Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D): review of 16 pediatric cases and a proposal of modified pediatric criteria, Pediatr Cardiol, 37, 646, 10.1007/s00246-015-1327-x Sreetharan, 2018, Clinical utility of endomyocardial biopsies in the diagnosis of arrhythmogenic right ventricular cardiomyopathy in children, Pediatr Res, 84, 552, 10.1038/s41390-018-0093-x Pieles, 2019, Association of echocardiographic parameters of right ventricular remodeling and myocardial performance with modified task force criteria in adolescents with arrhythmogenic right ventricular cardiomyopathy, Circ Cardiovasc Imaging, 12, 10.1161/CIRCIMAGING.118.007693 Bastiaenen, 2016, The ventricular ectopic QRS interval (VEQSI): diagnosis of arrhythmogenic right ventricular cardiomyopathy in patients with incomplete disease expression, Heart Rhythm, 13, 1504, 10.1016/j.hrthm.2016.03.039 Perrin, 2013, Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy, J Am Coll Cardiol, 62, 1772, 10.1016/j.jacc.2013.04.084 Denis, 2014, Diagnostic value of isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy, Circ Arrhythm Electrophysiol, 7, 590, 10.1161/CIRCEP.113.001224 Mariano-Goulart, 2007, Diagnosis of diffuse and localized arrhythmogenic right ventricular dysplasia by gated blood-pool SPECT, J Nucl Med, 48, 1416, 10.2967/jnumed.107.041129 Johnson, 2015, Comparison of radionuclide angiographic synchrony analysis to echocardiography and magnetic resonance imaging for the diagnosis of arrhythmogenic right ventricular cardiomyopathy, Heart Rhythm, 12, 1268, 10.1016/j.hrthm.2015.02.033 Tavora, 2012, Distribution of biventricular disease in arrhythmogenic cardiomyopathy: an autopsy study, Hum Pathol, 43, 592, 10.1016/j.humpath.2011.06.014 Corrado, 1997, Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study, J Am Coll Cardiol, 30, 1512, 10.1016/S0735-1097(97)00332-X Manyari, 1983, Arrhythmogenic right ventricular dysplasia: a generalized cardiomyopathy?, Circulation, 68, 251, 10.1161/01.CIR.68.2.251 Sen-Chowdhry, 2008, Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity, J Am Coll Cardiol, 52, 2175, 10.1016/j.jacc.2008.09.019 Steriotis, 2009, Electrocardiographic pattern in arrhythmogenic right ventricular cardiomyopathy, Am J Cardiol, 103, 1302, 10.1016/j.amjcard.2009.01.017 Chen, 2019, Early left ventricular involvement detected by cardiovascular magnetic resonance feature tracking in arrhythmogenic right ventricular cardiomyopathy: the effects of left ventricular late gadolinium enhancement and right ventricular dysfunction, J Am Heart Assoc, 8 Mast, 2015, Left ventricular involvement in arrhythmogenic right ventricular dysplasia/cardiomyopathy assessed by echocardiography predicts adverse clinical outcome, J Am Soc Echocardiogr, 28, 1103, 10.1016/j.echo.2015.04.015 Smith, 2020, Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy, Circulation, 141, 1872, 10.1161/CIRCULATIONAHA.119.044934 Corrado, 2020, Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria, Int J Cardiol, 319, 106, 10.1016/j.ijcard.2020.06.005 Vasaiwala, 2009, Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia, J Cardiovasc Electrophysiol, 20, 473, 10.1111/j.1540-8167.2008.01351.x Brosnan, 2018, Electrocardiographic features differentiating arrhythmogenic right ventricular cardiomyopathy from an athlete’s heart, J Am Coll Cardiol EP, 4, 1613 Calore, 2016, Electrocardiographic anterior T-wave inversion in athletes of different ethnicities: differential diagnosis between athlete’s heart and cardiomyopathy, Eur Heart J, 37, 2515, 10.1093/eurheartj/ehv591 Finocchiaro, 2019, Electrocardiographic differentiation between ‘benign T-wave inversion’ and arrhythmogenic right ventricular cardiomyopathy, Europace, 21, 332, 10.1093/europace/euy179 Gasperetti, 2021, Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC task force criteria, Heart Rhythm, 18, 231, 10.1016/j.hrthm.2020.09.015 Philips, 2014, Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear, Circ Arrhythm Electrophysiol, 7, 230, 10.1161/CIRCEP.113.000932 Steckman, 2012, Utility of cardiac magnetic resonance imaging to differentiate cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy, Am J Cardiology, 110, 575, 10.1016/j.amjcard.2012.04.029 Hoogendoorn, 2020, Electroanatomical voltage mapping to distinguish right-sided cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy, J Am Coll Cardiol EP, 6, 696 La Gerche, 2013, Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death, J Am Coll Cardiol Img, 6, 993, 10.1016/j.jcmg.2013.06.003 Prior, 2018, Differentiating athlete’s heart from cardiomyopathies - the right side, Heart Lung Circ, 27, 1063, 10.1016/j.hlc.2018.04.300 Prior, 2020, Exercise and arrhythmogenic right ventricular cardiomyopathy, Heart Lung Circ, 29, 547, 10.1016/j.hlc.2019.12.007 Zaidi, 2015, Clinical differentiation between physiological remodeling and arrhythmogenic right ventricular cardiomyopathy in athletes with marked electrocardiographic repolarization anomalies, J Am Coll Cardiol, 65, 2702, 10.1016/j.jacc.2015.04.035 D’Ascenzi, 2018, Diagnostic differentiation between arrhythmogenic cardiomyopathy and athlete’s heart by using imaging, J Am Coll Cardiol Img, 11, 1327, 10.1016/j.jcmg.2018.04.031 Luijkx, 2012, Impact of revised task force criteria: distinguishing the athlete’s heart from ARVC/D using cardiac magnetic resonance imaging, Eur J Prev Cardiol, 19, 885, 10.1177/1741826711414215 Kübler, 2021, Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy, Int J Cardiovasc Imaging, 37, 2501, 10.1007/s10554-021-02280-6 Corrado, 2003, Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia, Circulation, 108, 3084, 10.1161/01.CIR.0000103130.33451.D2 Corrado, 2010, Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia, Circulation, 122, 1144, 10.1161/CIRCULATIONAHA.109.913871 Canpolat, 2013, Fragmented QRS complex predicts the arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia, J Cardiovasc Electrophysiol, 24, 1260, 10.1111/jce.12202 Bhonsale, 2013, Risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers, Circ Arrhythm Electrophysiol, 6, 569, 10.1161/CIRCEP.113.000233 Rigato, 2013, Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy, Circ Cardiovasc Genet, 6, 533, 10.1161/CIRCGENETICS.113.000288 Mazzanti, 2016, Arrhythmogenic right ventricular cardiomyopathy: clinical course and predictors of arrhythmic risk, J Am Coll Cardiol, 68, 2540, 10.1016/j.jacc.2016.09.951 Martin, 2016, High arrhythmic burden but low mortality during long-term follow-up in arrhythmogenic right ventricular cardiomyopathy, Heart Lung Circ, 25, 275, 10.1016/j.hlc.2015.08.019 Kimura, 2016, Potentially lethal ventricular arrhythmias and heart failure in arrhythmogenic right ventricular cardiomyopathy: what are the differences between men and women?, J Am Coll Cardiol EP, 2, 546 Lin, 2017, Gender differences in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical manifestations, electrophysiological properties, substrate characteristics, and prognosis of radiofrequency catheter ablation, Int J Cardiol, 227, 930, 10.1016/j.ijcard.2016.11.055 Orgeron, 2017, Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular dysplasia/cardiomyopathy: predictors of appropriate therapy, outcomes, and complications, J Am Heart Assoc, 6 Maupain, 2018, Risk stratification in arrhythmogenic right ventricular cardiomyopathy/dysplasia without an implantable cardioverter-defibrillator, J Am Coll Cardiol EP, 4, 757 Lie, 2018, Prediction of life-threatening ventricular arrhythmia in patients with arrhythmogenic cardiomyopathy: a primary prevention cohort study, J Am Coll Cardiol Img, 11, 1377, 10.1016/j.jcmg.2018.05.017 Cadrin-Tourigny, 2019, A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy, Eur Heart J, 40, 1850, 10.1093/eurheartj/ehz103 Cadrin-Tourigny, 2021, Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy: a multinational collaboration, Circ Arrhythm Electrophysiol, 14, 10.1161/CIRCEP.120.008509 Turrini, 1999, Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy, Am J Cardiol, 83, 1214, 10.1016/S0002-9149(99)00062-4 Turrini, 2001, Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy, Circulation, 103, 3075, 10.1161/01.CIR.103.25.3075 Roguin, 2004, Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy, J Am Coll Cardiol, 43, 1843, 10.1016/j.jacc.2004.01.030 Pezawas, 2006, Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up, Int J Cardiol, 107, 360, 10.1016/j.ijcard.2005.03.049 Bhonsale, 2011, Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention, J Am Coll Cardiol, 58, 1485, 10.1016/j.jacc.2011.06.043 Santangeli, 2012, Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study, Heart Rhythm, 9, 1200, 10.1016/j.hrthm.2012.03.057 Migliore, 2013, Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia, Circ Arrhythm Electrophysiol, 6, 167, 10.1161/CIRCEP.111.974881 Cappelletto, 2018, Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment, Europace, 20, f20, 10.1093/europace/eux093 Orgeron, 2018, Performance of the 2015 International Task Force consensus statement risk stratification algorithm for implantable cardioverter-defibrillator placement in arrhythmogenic right ventricular dysplasia/cardiomyopathy, Circ Arrhythm Electrophysiol, 11, 10.1161/CIRCEP.117.005593 Aquaro, 2018, Prognostic role of cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy, Am J Cardiol, 122, 1745, 10.1016/j.amjcard.2018.08.007 Wichter, 2004, Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients, Circulation, 109, 1503, 10.1161/01.CIR.0000121738.88273.43 Sarvari, 2011, Right ventricular mechanical dispersion is related to malignant arrhythmias: a study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction, Eur Heart J, 32, 1089, 10.1093/eurheartj/ehr069 Aquaro, 2020, Prognostic value of magnetic resonance phenotype in patients with arrhythmogenic right ventricular cardiomyopathy, J Am Coll Cardiol, 75, 2753, 10.1016/j.jacc.2020.04.023 Kirkels, 2021, Right ventricular functional abnormalities in arrhythmogenic cardiomyopathy: association with life-threatening ventricular arrhythmias, J Am Coll Cardiol Img, 14, 900, 10.1016/j.jcmg.2020.12.028 Kikuchi, 2016, Long-term prognostic role of the diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy/dysplasia, J Am Coll Cardiol EP, 2, 107 Piccini, 2005, Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia, Heart Rhythm, 2, 1188, 10.1016/j.hrthm.2005.08.022 Akdis, 2017, Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome, Eur Heart J, 38, 1498, 10.1093/eurheartj/ehx011 Rootwelt-Norberg, 2021, Sex differences in disease progression and arrhythmic risk in patients with arrhythmogenic cardiomyopathy, Europace, 23, 1084, 10.1093/europace/euab077 James, 2013, Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers, J Am Coll Cardiol, 62, 1290, 10.1016/j.jacc.2013.06.033 Saberniak, 2014, Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members, Eur J Heart Fail, 16, 1337, 10.1002/ejhf.181 Wang, 2020, Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients, Europace, 22, 1270, 10.1093/europace/euaa105 La Gerche, 2012, Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes, Eur Heart J, 33, 998, 10.1093/eurheartj/ehr397 La Gerche, 2017, Exercise and the right ventricle: a potential Achilles’ heel, Cardiovasc Res, 113, 1499, 10.1093/cvr/cvx156 La Gerche, 2010, Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin, Heart, 96, 1268, 10.1136/hrt.2009.189621 Lie, 2021, Cardiac Phenotypes and markers of adverse outcome in elite athletes with ventricular arrhythmias, J Am Coll Cardiol Img, 14, 148, 10.1016/j.jcmg.2020.07.039 Castrini, 2019, Number of pregnancies and subsequent phenotype in a cross-sectional cohort of women with arrhythmogenic cardiomyopathy, Eur Heart J Cardiovasc Imaging, 20, 192, 10.1093/ehjci/jey061 Wu, 2020, Effect of pregnancy in arrhythmogenic right ventricular cardiomyopathy, Am J Cardiol, 125, 613, 10.1016/j.amjcard.2019.11.008 Zorzi, 2013, Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification, J Cardiovasc Electrophysiol, 24, 1321, 10.1111/jce.12246 Kubala, 2018, Electrocardiographic repolarization abnormalities and electroanatomic substrate in arrhythmogenic right ventricular cardiomyopathy, Circ Arrhythm Electrophysiol, 11, 10.1161/CIRCEP.117.005553 Vischer, 2019, Risk score for the exclusion of arrhythmic events in arrhythmogenic right ventricular cardiomyopathy at first presentation, Int J Cardiol, 290, 100, 10.1016/j.ijcard.2019.04.090 Hodgkinson, 2016, Long-term clinical outcome of arrhythmogenic right ventricular cardiomyopathy in individuals with a p.S358L mutation in tmem43 following implantable cardioverter defibrillator therapy, Circ Arrhythm Electrophysiol, 9, 10.1161/CIRCEP.115.003589 Verstraelen, 2021, Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction, Eur Heart J, 42, 2842, 10.1093/eurheartj/ehab294 Corrado, 2015, Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement, Eur Heart J., 36, 3227 Baudinaud, 2021, External validation of a risk prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy, Can J Cardiol, 37, 1263, 10.1016/j.cjca.2021.02.018 Hulot, 2004, Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy, Circulation, 110, 1879, 10.1161/01.CIR.0000143375.93288.82 Pinamonti, 2011, Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry, Eur Heart J, 32, 1105, 10.1093/eurheartj/ehr040 Saguner, 2013, Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy, Am J Cardiol, 111, 250, 10.1016/j.amjcard.2012.09.025 Liao, 2014, Risk stratification of arrhythmogenic right ventricular cardiomyopathy based on signal averaged electrocardiograms, Int J Cardiol, 174, 628, 10.1016/j.ijcard.2014.04.169 Saguner, 2014, Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasia, Am J Cardiol, 113, 1728, 10.1016/j.amjcard.2014.02.031 Saguner, 2014, Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia, Circ Cardiovasc Imaging, 7, 230, 10.1161/CIRCIMAGING.113.000210 Wang, 2018, Impact of exercise restriction on arrhythmic risk among patients with arrhythmogenic right ventricular cardiomyopathy, J Am Heart Assoc, 7 Gasperetti, 2020, Novel risk calculator performance in athletes with arrhythmogenic right ventricular cardiomyopathy, Heart Rhythm, 17, 1251, 10.1016/j.hrthm.2020.03.007 Lin, 2019, Characteristics of recurrent ventricular tachyarrhythmia after catheter ablation in patients with arrhythmogenic right ventricular cardiomyopathy, J Cardiovasc Electrophysiol, 30, 582, 10.1111/jce.13853 La Gerche, 2015, Defining the interaction between exercise and arrhythmogenic right ventricular cardiomyopathy, Eur J Heart Fail, 17, 128, 10.1002/ejhf.224 Ruwald, 2015, Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy, Eur Heart J, 36, 1735, 10.1093/eurheartj/ehv110 Wichter, 1992, Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia, Circulation, 86, 29, 10.1161/01.CIR.86.1.29 Marcus, 2009, Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry, J Am Coll Cardiol, 54, 609, 10.1016/j.jacc.2009.04.052 Al-Khatib, 2018, J Am Coll Cardiol, 72, 1677, 10.1016/j.jacc.2017.10.053 Ermakov, 2017, Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy, Heart Rhythm, 14, 564, 10.1016/j.hrthm.2016.12.010 Asimaki, 2014, Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy, Sci Transl Med, 6, 240ra74, 10.1126/scitranslmed.3008008 Chelko, 2016, Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy, JCI Insight, 1, 10.1172/jci.insight.85923 Roberts, 2019, Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy, J Clin Invest, 129, 3171, 10.1172/JCI125538 Olde Nordkamp, 2016, Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications, Heart Rhythm, 13, 443, 10.1016/j.hrthm.2015.09.010 O'Mahony, 2014, A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD), Eur Heart J, 35, 2010, 10.1093/eurheartj/eht439 Herman, 2016, Long-term right ventricular implantable cardioverter-defibrillator lead performance in arrhythmogenic right ventricular cardiomyopathy, Heart Rhythm, 13, 1964, 10.1016/j.hrthm.2016.06.021 Orgeron, 2018, Subcutaneous implantable cardioverter-defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: a transatlantic experience, J Am Heart Assoc, 7 Bai, 2011, Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation, Circ Arrhythm Electrophysiol, 4, 478, 10.1161/CIRCEP.111.963066 Romero, 2020, Endo-epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis, J Cardiovasc Electrophysiol, 31, 2022, 10.1111/jce.14593 Müssigbrodt, 2017, Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation?, J Interv Card Electrophysiol, 48, 193, 10.1007/s10840-016-0209-3 Mathew, 2019, Catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: a sequential approach, J Am Heart Assoc, 8 Garcia, 2009, Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia, Circulation, 120, 366, 10.1161/CIRCULATIONAHA.108.834903 Philips, 2015, Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy, Heart Rhythm, 12, 716, 10.1016/j.hrthm.2014.12.018 Lin, 2018, Heterogeneous distribution of substrates between the endocardium and epicardium promotes ventricular fibrillation in arrhythmogenic right ventricular dysplasia/cardiomyopathy, Europace, 20, 501, 10.1093/europace/euw393 Ustunkaya, 2019, Epicardial conduction speed, electrogram abnormality, and computed tomography attenuation associations in arrhythmogenic right ventricular cardiomyopathy, J Am Coll Cardiol EP, 5, 1158 Philips, 2012, Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy, Circ Arrhythm Electrophysiol, 5, 499, 10.1161/CIRCEP.111.968677 Komatsu, 2014, Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia, J Am Coll Cardiol, 63, 1416, 10.1016/j.jacc.2013.10.087 Philips, 2013, High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy, Circ Arrhythm Electrophysiol, 6, 160, 10.1161/CIRCEP.112.975441 Berte, 2015, Characterization of the left-sided substrate in arrhythmogenic right ventricular cardiomyopathy, Circ Arrhythm Electrophysiol, 8, 1403, 10.1161/CIRCEP.115.003213 O’Donnell, 2003, Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia, Eur Heart J, 24, 801, 10.1016/S0195-668X(02)00654-1 Santangeli, 2019, Outcomes of catheter ablation in arrhythmogenic right ventricular cardiomyopathy without background implantable cardioverter defibrillator therapy: a multicenter international ventricular tachycardia registry, J Am Coll Cardiol EP, 5, 55 Daimee, 2021, Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: insights from the Johns Hopkins ARVC Program, Heart Rhythm, 18, 1369, 10.1016/j.hrthm.2021.04.028 Liang, 2020, Catheter ablation of arrhythmogenic right ventricular cardiomyopathy ventricular tachycardia: 18-year experience in 284 patients, Europace, 22, 806, 10.1093/europace/euaa046 Yoda, 2005, Three cases of orthotopic heart transplantation for arrhythmogenic right ventricular cardiomyopathy, Ann Thorac Surg, 80, 2358, 10.1016/j.athoracsur.2004.07.071 Tedford, 2012, Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy, J Am Coll Cardiol, 59, 289, 10.1016/j.jacc.2011.09.051 DePasquale, 2017, Survival after heart transplantation in patients with arrhythmogenic right ventricular cardiomyopathy, J Card Fail, 23, 107, 10.1016/j.cardfail.2016.04.020 Norman, 2005, Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy, Circulation, 112, 636, 10.1161/CIRCULATIONAHA.104.532234 López-Ayala, 2014, Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype, Europace, 16, 1838, 10.1093/europace/euu128 Hermida, 2019, High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia, Eur J Heart Fail, 21, 792, 10.1002/ejhf.1423 Saberniak, 2017, Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia, Eur Heart J Cardiovasc Imaging, 18, 62, 10.1093/ehjci/jew014 Malik, 2020, Right ventricular strain predicts structural disease progression in patients with arrhythmogenic right ventricular cardiomyopathy, J Am Heart Assoc, 9 Mast, 2016, Right ventricular imaging and computer simulation for electromechanical substrate characterization in arrhythmogenic right ventricular cardiomyopathy, J Am Coll Cardiol, 68, 2185, 10.1016/j.jacc.2016.08.061 Chatterjee, 2018, An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis, Eur Heart J, 39, 3932, 10.1093/eurheartj/ehy567 Asimaki, 2009, A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy, N Engl J Med, 360, 1075, 10.1056/NEJMoa0808138